An international, peer reviewed, open access journal that aims to support those engaged in research on biomarkers and cancer, by providing rapid communication of the latest advances in the application of biomarkers toward discovery of new knowledge and clinical application of that knowledge.
Editor in Chief: Dr. Barbara Guinn
Processing Speed: High quality, constructive peer review and rapid editorial decision within an average of four weeks.
Sign up for email alerts to receive notifications of new articles published in Biomarkers in Cancer
Publishing with Libertas Academica is unlike any other experience I have had. The process was totally up-to-date and responses to my queries received prompt replies, the whole time. These two features alone are worth the whole experience.